Product Literature
| NDC | PRODUCT NAME | SELL SHEET | ||
| 17478-542-02 | Adenosine Injection, USP 2 mL 3 mg/mL Vial |  | ||
| 17478-253-10 | AK-Fluor® (fluorescein injection, USP) 5 mL 10% Single-dose Vial | | ||
| 17478-250-20 | AK-Fluor® (fluorescein injection, USP) 2 mL 25% Single-dose Vial | | ||
| 17478-792-01 | Akten® (lidocaine hydrochloride ophthalmic gel) 1 mL 3.5% Sterile Ophthalmic Gel in a Unit-dose Tube | | ||
| 17478-067-02 | Alfenta® CII (alfentanil hydrochloride injection) 2 mL 500 mcg/mL Single-dose Ampule CII | | ||
| 17478-067-05 | Alfenta® CII (alfentanil hydrochloride injection) 5 mL 500 mcg/mL Single-dose Ampule CII | | ||
| 17478-716-10 | Apraclonidine Ophthalmic Solution, USP 5 mL 0.5% as Base Sterile Ophthalmic Solution | | ||
| 17478-716-11 | Apraclonidine Ophthalmic Solution, USP 10 mL 0.5% as Base Sterile Ophthalmic Solution | | ||
| 17478-214-20 | Atropine Care™ (atropine sulfate ophthalmic solution) 2 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-214-10 | Atropine Care™ (atropine sulfate ophthalmic solution) 5 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-214-12 | Atropine Care™ (atropine sulfate ophthalmic solution) 15 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-214-20 | Atropine Sulfate Ophthalmic Solution 2 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-214-10 | Atropine Sulfate Ophthalmic Solution 5 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-214-12 | Atropine Sulfate Ophthalmic Solution 15 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-526-03 | BAL In Oil™ (dimercaprol injection, USP) 3 mL 100 mg/mL Single-dose Ampule | | ||
| 17478-012-02 | Benztropine Mesylate Injection, USP 2 mL 1 mg/mL Ampule | | ||
| 17478-705-11 | Betaxolol Ophthalmic Solution, USP 10 mL 0.5%Sterile Ophthalmic Solution | | ||
| 17478-705-10 | Betaxolol Ophthalmic Solution, USP 5 mL 0.5%Sterile Ophthalmic Solution | | ||
| 17478-715-10 | Brimonidine Tartrate Ophthalmic Solution 5 mL 0.2% Sterile Ophthalmic Solution | | ||
| 17478-715-11 | Brimonidine Tartrate Ophthalmic Solution 10 mL 0.2% Sterile Ophthalmic Solution | | ||
| 17478-715-12 | Brimonidine Tartrate Ophthalmic Solution 15 mL 0.2% Sterile Ophthalmic Solution | | ||
| 17478-931-01 | Calcitriol lnjection 1 mL 1 mcg/mL Single-dose Ampule | | ||
| 17478-080-50 | Capastat® Sulfate (capreomycin for injection, USP) 10 mL 1 g Lyophilized Vial | | ||
| 17478-419-40 | Chlorothiazide Sodium N/A 0.5 g Lyophilized White Powder Vial | | ||
| 17478-714-10 | Ciprofloxacin Ophthalmic Solution, USP 5 mL 0.3% as Base Sterile Ophthalmic Solution | | ||
| 76478-611-02 | Cogentin® (benztropine mesylate injection) 2 mL 1 mg/mL Ampule | | ||
| 17478-100-02 | Cyclopentolate Hydrochloride Ophthalmic Solution, USP 2 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-100-12 | Cyclopentolate Hydrochloride Ophthalmic Solution, USP 15 mL 1% Sterile Ophthalmic Solution | | ||
| 17478-097-02 | Cyclopentolate Hydrochloride Ophthalmic Solution, USP 2 mL 2% Sterile Ophthalmic Solution | | ||
| 17478-097-10 | Cyclopentolate Hydrochloride Ophthalmic Solution, USP 5 mL 2% Sterile Ophthalmic Solution | | ||
| 17478-097-12 | Cyclopentolate Hydrochloride Ophthalmic Solution, USP 15 mL 2% Sterile Ophthalmic Solution | | ||
| 17478-503-05 | Dehydrated Alcohol Injection, USP 5 mL Not Less Than 98% by Volume of Ethanol (Ethyl Alcohol) Single-dose Vial | | ||
| 17478-892-25 | Diclofenac Sodium Ophthalmic Solution 2.5 mL 0.1% Sterile Ophthalmic Solution | | ||
| 17478-892-10 | Diclofenac Sodium Ophthalmic Solution 5 mL 0.1% Sterile Ophthalmic Solution | | ||
| 17478-937-05 | Diltiazem Hydrochloride Injection 5 mL 5 mg/mL Single-dose Vial | | ||
| 17478-937-10 | Diltiazem Hydrochloride Injection 10 mL 5 mg/mL Single-dose Vial | | ||
| 17478-937-25 | Diltiazem Hydrochloride Injection 25 mL 5 mg/mL Single-dose Vial | | ||
| 63323-289-55 | EMLA® Cream (lidocaine 2.5% and prilocaine 2.5%) 5 g 2.5% Lidocaine and 2.5% Prilocaine | | ||
| 76478-289-30 | EMLA® Cream (lidocaine 2.5% and prilocaine 2.5%) 30 g 2.5% Lidocaine and 2.5% Prilocaine | | ||
| 17478-515-00 | Ephedrine Sulfate Injection, USP 1 mL 50 mg/mL Single-dose Ampule | | ||
| 17478-070-35 | Erythromycin Ophthalmic Ointment, USP 3.5 g 0.5% Sterile Ophthalmic Ointment | | ||
| 17478-070-31 | Erythromycin Ophthalmic Ointment, USP 1 g 0.5% Sterile Ophthalmic Ointment | | ||
| 17478-640-10 | Fluress® (fluorescein sodium and benoxinate hydrochloride ophthalmic solution, USP) 5 mL Fluorescein Sodium 0.25% and Benoxinate HCl 0.4% Sterile Ophthalmic Solution, with Separate Sterile Dropper | | ||
| 17478-403-03 | Ful-Glo® (fluorescein sodium strips, USP) Strip 0.6 mg Individually Wrapped Sterile Ophthalmic Strips | | ||
| 17478-404-01 | Ful-Glo® (fluorescein sodium strips, USP) Strip 1.0 mg Individually Wrapped Sterile Ophthalmic Strips | | ||
| 17478-284-35 | Gentak® (gentamicin sulfate ophthalmic ointment, USP) 3.5 g 0.3% Sterile Ophthalmic Ointment | | ||
| 17478-283-10 | Gentak® (gentamicin sulfate ophthlamic solution, USP) 5 mL 0.3% Sterile Ophthalmic Solution | | ||
| 17478-283-10 | Gentamicin Sulfate Ophthlamic Solution, USP 5 mL 0.3% Sterile Ophthalmic Solution | | ||
| 17478-064-12 | Gonak™ (hypromellose ophthalmic demulcent solution) 15 mL 2.5% Sterile Hypromellose Ophthalmic Demulcent Solution | | ||
| 17478-546-02 | Granisetron Hydrochloride Injection, USP 1 mL 1 mg/mL Single-use Vial | | ||
| 17478-546-05 | Granisetron Hydrochloride Injection, USP 4 mL 1 mg/mL Multi-use Vial | | ||
| 17478-934-01 | HydrALAZINE Hydrochloride Injection, USP 1 mL 20 mg/mL Single-dose Vial | | ||
| 17478-934-15 | HydrALAZINE Hydrochloride Injection, USP 1 mL 20 mg/mL Single-dose Vial | | ||
| 17478-540-01 | Hydromorphone Hydrochloride, USP CII (High Potency Formulation) 1 mL 10 mg/mL Single-dose Amber Ampule CII | | ||
| 17478-540-05 | Hydromorphone Hydrochloride, USP CII (High Potency Formulation) 5 mL 10 mg/mL Single-dose Amber Ampule CII | | ||
| 17478-540-50 | Hydromorphone Hydrochloride, USP CII (High Potency Formulation) 50 mL 10 mg/mL Single-dose Vial CII | | ||
| 17478-701-02 | IC-Green™ (indocyanine green for injection, USP) 25 mg Vial and 10 mL Ampule (Solvent) 25 mg Sterile Indocyanine Green Single-dose Vials and Sterile Aqueous Solvent Ampules | | ||
| 17478-508-01 | Indigo Carmine™ (indigotindisulfonate sodium injection, USP) 5 mL 8 mg/mL Single-dose Ampule | | ||
| 17478-208-10 | Ketorolac Tromethamine Ophthalmic Solution, 0.4% 5 mL 0.4% Sterile Ophthalmic Solution | | ||
| 17478-209-19 | Ketorolac Tromethamine Ophthalmic Solution, 0.5% 3 mL 0.5% Sterile Ophthalmic Solution | | ||
| 17478-209-10 | Ketorolac Tromethamine Ophthalmic Solution, 0.5% 5 mL 0.5% Sterile Ophthalmic Solution | | ||
| 17478-209-11 | Ketorolac Tromethamine Ophthalmic Solution, 0.5% 10 mL 0.5% Sterile Ophthalmic Solution | | ||
| 17478-420-20 | Labetalol Hydrochloride Injection, USP 20 mL 5 mg/mL Multi-dose Vial | | ||
| 17478-420-40 | Labetalol Hydrochloride Injection, USP 40 mL 5 mg/mL Multi-dose Vial | | ||
| 17478-625-12 | Latanoprost Ophthalmic Solution 2.5 mL 0.005% Sterile Ophthalmic Solution | | ||
| 17478-107-20 | Levofloxacin Injection, for Intravenous Use 20 mL 25 mg/mL, Single-dose Vial (equivalent to 500 mg of levofloxacin) | | ||
| 17478-107-30 | Levofloxacin Injection, for Intravenous Use 30 mL 25 mg/mL, Single-dose Vial (equivalent to 750 mg of levofloxacin) | | ||
| 17478-106-10 | Levofloxacin Ophthalmic Solution 5 mL 0.5% Sterile Ophthalmic Solution | | ||
| 17478-190-55 | Lidocaine 2.5% and Prilocaine 2.5% Cream, USP 5 g Lidocaine 2.5% and Prilocaine 2.5% | | ||
| 17478-190-30 | Lidocaine 2.5% and Prilocaine 2.5% Cream, USP 30 g Lidocaine 2.5% and Prilocaine 2.5% | | ||
| 17478-711-10 | Lidocaine Hydrochloride Jelly, USP 5 mL 2% Sterile Jelly | | ||
| 17478-711-30 | Lidocaine Hydrochloride Jelly, USP 30 mL 2% Sterile Jelly | | ||
| 17478-040-01 | Lorazepam Injection, USP CIV 1 mL 2 mg/mL Single-dose Vial CIV | | ||
| 17478-504-01 | Methylene Blue Injection, USP 1 mL 10 mg/mL Single-dose Vial | | ||
| 17478-504-10 | Methylene Blue Injection, USP 10 mL 10 mg/mL Single-dose Vial | | ||
| 17478-501-01 | Methylergonovine Maleate Injection, USP 1 mL 0.2 mg/mL Ampule | | ||
| 17478-524-01 | Midazolam Injection, USP CIV 1 mL 5 mg/mL Vial | | ||
| 17478-524-02 | Midazolam Injection, USP CIV 2 mL 5 mg/mL Vial | | ||
| 17478-524-05 | Midazolam Injection, USP CIV 5 mL 5 mg/mL Vial | | ||
| 17478-524-10 | Midazolam Injection, USP CIV 10 mL 5 mg/mL Vial | | ||
| 17478-523-02 | Midazolam Injection, USP CIV 2 mL 1 mg/mL Vial | | ||
| 17478-523-55 | Midazolam Injection, USP CIV 5 mL 1 mg/mL Vial | | ||
| 17478-523-10 | Midazolam Injection, USP CIV 10 mL 1 mg/mL Vial | | ||
| 76478-501-20 | Nembutal® Sodium Solution CII (pentobarbital sodium injection, USP) 20 mL 50 mg/mL Multi-dose Vial | | ||
| 76478-501-50 | Nembutal® Sodium Solution CII (pentobarbital sodium injection, USP) 50 mL 50 mg/mL Multi-dose Vial | | ||
| 17478-235-35 | Neomycin and Polymyxin B Sulfates and Bacitracin Zinc Ophthalmic Ointment, USP 3.5 g Neomycin Sulfate (equivalent to 3.5 mg Neomycin base), Polymyxin B Sulfate equal to 10,000 Polymyxin B units, Bacitracin Zinc equal to 400 Bacitracin units and White Petrolatum, q.s. Sterile Ophthalmic Ointment | | ||
| 17478-713-10 | Ofloxacin Ophthalmic Solution, USP 5 mL 0.3% Sterile Ophthalmic Solution | | ||
| 17478-713-11 | Ofloxacin Ophthalmic Solution, USP 10 mL 0.3% Sterile Ophthalmic Solution | | ||
| 17478-538-02 | Orphenadrine Citrate Injection, USP 2 mL 30 mg/mL Single-dose Vial | | ||
| 17478-069-14 | Pantoprazole Sodium for Injection N/A 40 mg Lyophilized Single-dose Vial | | ||
| 17478-704-12 | Paremyd® (hydroxyamphetamine hydrobromide and tropicamide ophthalmic solution) 15 mL Hydroxyamphetamine Hydrobromide 1% and Tropicamide 0.25% Ophthalmic Solution | | ||
| 17478-200-20 | Phenylephrine Hydrochloride Ophthalmic Solution, USP 2 mL 2.5% Sterile Ophthalmic Solution | | ||
| 17478-200-12 | Phenylephrine Hydrochloride Ophthalmic Solution, USP 15 mL 2.5% Sterile Ophthalmic Solution | | ||
| 17478-205-10 | Phenylephrine Hydrochloride Ophthalmic Solution, USP 5 mL 10% Sterile Ophthalmic Solution | | ||
| 17478-766-10 | Progesterone Capsules Bottle of 100 100 mg Capsules | | ||
| 17478-767-10 | Progesterone Capsules Bottle of 100 200 mg Capsules | | ||
| 17478-151-42 | Rifampin for Injection, USP N/A 600 mg Lyophilized Vial | | ||
| 76478-711-40 | Sodium Diuril® (chlorothiazide sodium) N/A 0.5 g Lyophilized White Powder Vial | | ||
| 17478-030-02 | Sublimaze® CII (fentanyl citrate injection) 2 mL 50 mcg/mL Ampule | | ||
| 17478-030-05 | Sublimaze® CII (fentanyl citrate injection) 5 mL 50 mcg/mL Ampule | | ||
| 17478-030-20 | Sublimaze® CII (fentanyl citrate injection) 20 mL 50 mcg/mL Ampule | | ||
| 17478-030-25 | Sublimaze® CII (fentanyl citrate injection) 2 mL 50 mcg/mL Ampule | | ||
| 17478-030-55 | Sublimaze® CII (fentanyl citrate injection) 5 mL 50 mcg/mL Ampule | | ||
| 17478-050-01 | Sufenta® CII (sufentanil citrate injection) 1 mL 50 mcg/mL Ampule CII | | ||
| 17478-050-02 | Sufenta® CII (sufentanil citrate injection) 2 mL 50 mcg/mL Ampule CII | | ||
| 17478-050-05 | Sufenta® CII (sufentanil citrate injection) 5 mL 50 mcg/mL Ampule CII | | ||
| 17478-131-01 | Tetanus and Diphtheria Toxoids Adsorbed 0.5 mL 2 Lf of Tetanus Toxoid and 2 Lf of Diphtheria Toxoid Single-dose Vial for Age 7 Years and Older | | ||
| 17478-288-10 | Timolol Maleate Ophthalmic Solution, USP 5 mL 0.5% Sterile Ophthalmic Solution | | ||
| 17478-288-11 | Timolol Maleate Ophthalmic Solution, USP 10 mL 0.5% Sterile Ophthalmic Solution | | ||
| 17478-288-12 | Timolol Maleate Ophthalmic Solution, USP 15 mL 0.5% Sterile Ophthalmic Solution | | ||
| 17478-741-02 | Vancomycin Hydrochloride Capsules, USP 2 Blister Cards of 10 Capsules 125 mg* Capsules (*Equivalent to Vancomycin) | | ||
| 17478-742-02 | Vancomycin Hydrochloride Capsules, USP 2 Blister Cards of 10 Capsules 250 mg* Capsules (*Equivalent to Vancomycin) | | ||
| 63323-479-30 | Xylocaine® (lidocaine hydrochloride) 30 mL 2% Sterile Jelly | |
Don't have Adobe Acrobat or Adobe Reader? DOWNLOAD HERE